Invivyd (IVVD) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
19 May, 2026Opening remarks and agenda
Meeting called to order by the Chairman, with introductions of directors, legal counsel, and the independent auditor.
Virtual format enabled broader stockholder participation and access to agenda and procedures.
Stockholders instructed on question submission and voting procedures.
Board and executive committee updates
Six nominees for director were presented for election to serve one-year terms expiring at the 2027 annual meeting.
Shareholder proposals
Two proposals were presented: election of directors and ratification of the independent auditor.
No additional proposals were submitted in accordance with bylaws and applicable law.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Invivyd
- PEMGARDA revenue up 22% YoY to $13.7M; net loss $41.4M; VYD2311 trial on track for Q3 data.IVVD
Q1 202614 May 2026 - VYD2311 and VMS063 advance in pivotal COVID-19 and measles studies, targeting urgent unmet needs.IVVD
Study update9 Apr 2026 - Shareholders will elect six directors and vote on auditor ratification at the 2026 annual meeting.IVVD
Proxy filing6 Apr 2026 - Six independent directors up for election and auditor ratification headline the annual meeting.IVVD
Proxy filing6 Apr 2026 - Q4 PEMGARDA revenue up 25% YoY to $17.2M; DECLARATION trial fully enrolled for mid-2026 data.IVVD
Q4 20255 Mar 2026 - Strong early uptake of PEMGARDA supports $150–$200M revenue guidance and robust cash outlook.IVVD
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - PEMGARDA launch drove $2.3M Q2 revenue, but cash runway is under one year.IVVD
Q2 20241 Feb 2026 - Pemgarda sees strong launch in immunocompromised COVID-19 prevention; next-gen antibody in trials.IVVD
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Rapid Pemgarda launch targets unmet needs in immunocompromised COVID-19 patients.IVVD
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026